加替沙星注射液治疗非淋菌性尿道(宫颈)炎临床观察

Treatment of non-gonococcal urethritis(cervicitis) with gatifoxacin injection

目的:观察静滴加替沙星氯化钠注射液治疗非淋菌性尿道(宫颈)炎的临床疗效和安全性。方法:对沙眼衣原体(CT)或/和解脲脲原体(Uu)所感染的非淋菌性尿道(宫颈)炎患者162例,采用加替沙星氯化钠注射液静脉滴注给药的方法,每天1次,每次0.4g,连续14天。结果:162例患者痊愈率为69.1%,总有效率为84%,沙眼衣原体(CT)和解脲脲原体(UU)病原体感染清除率分别为83.5%和84.6%,不良反应发生率较低,为4.9%。结论:加替沙星氯化钠注射液治疗非淋菌性尿道(宫颈)炎疗效好,安全性好。

Objectives： To observe the clinical effect and safety of Gatifoxacin injection on the treatment of non -gonococcal urethritis. Methods： Gatifoxacin injection was administrated intravenously to 162 patients with CT and Uu non - gonococcal urethritis, with the dosage of 0.4 mg each time, once a day, continuing 14 days. Results： Among the 162 patients with such treatment, the recovery rate was 69.1% , overall efficacy rate was 84% , CT and UU infection clearance rates were 83.5% and 84.6% respectively, and the adverse reaction rate was low, taking up only 4.9%. Conclusion： Gatifoxacin is proved to have favorable and safe therapeutic effect on non - gnonococcal urethfitis （cervicitis）.